Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 11—November 2026
Research
Five-Biomarker Definition for Hypervirulent Klebsiella pneumoniae Bloodstream Infection and Abscess Complications, Japan, 2022–2024
Figure 3

Figure 3. Maximum-likelihood phylogeny of 164 isolates from study of 5-biomarker definition for hypervirulent Klebsiella pneumoniae bloodstream infection and abscess complications, Japan, 2022–2024. The tree was inferred from a recombination-filtered core genome single-nucleotide polymorphism alignment. Annotation tracks indicate the ST, KL capsule type, biomarker group, abscess complication, and ESBL status. ESBL, extended-spectrum β-lactamase; KL, K-locus; ST, sequence type.
Page created: September 16, 2026
Page updated: October 14, 2026
Page reviewed: October 14, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.